Akanda (AKAN) vs Regencell Bioscience (RGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Regencell Bioscience is the larger company by market cap ($3.74 billion vs $4.7 million), about 790.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AKAN | RGC |
|---|---|---|
| Share price | $1.79 | $7.54 |
| Market cap | $4.72M | $3.74B |
| 1-day change | +0.56% | -1.25% |
| YTD return | — | -63.67% |
| 1-year return | — | -60.67% |
| 5-year return | — | +1455.56% |
| EPS (TTM) | $-14,935.32 | $-0.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | — | $-11.70M |
| 52-week high | $78.90 | $69.00 |
| 52-week low | $1.73 | $4.51 |
| Distance from 52-week high | -97.73% | -89.08% |
| Average volume | 1.35M | 199.19K |
| Shares outstanding | 2.39M | 495.88M |
| Employees | — | 10 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Regencell Bioscience is about 790.9 times larger than Akanda by market value ($3.74B vs $4.72M).
About Akanda
AKAN stock →Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers.
Health Care · Medicinal Chemicals and Botanical Products
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
AKAN vs RGC FAQ
Which is bigger, Akanda or Regencell Bioscience?
Regencell Bioscience (RGC) is larger, with a market capitalization of $3.74B compared with $4.72M for Akanda (AKAN).
Are Akanda and Regencell Bioscience in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.